| 注册
首页|期刊导航|国际医药卫生导报|曲安奈德益康唑联合丹参酮治疗面部脂溢性皮炎的临床疗效研究

曲安奈德益康唑联合丹参酮治疗面部脂溢性皮炎的临床疗效研究

王晓丽 张美丽 栾照敏 王培圣

国际医药卫生导报2017,Vol.23Issue(4):557-559,3.
国际医药卫生导报2017,Vol.23Issue(4):557-559,3.DOI:10.3760/cma.j.issn.1007-1245.2017.04.035

曲安奈德益康唑联合丹参酮治疗面部脂溢性皮炎的临床疗效研究

Study on clinical effect of Pevisone combined with tanshinone in the treatment of facial seborrheic dermatitis

王晓丽 1张美丽 1栾照敏 1王培圣1

作者信息

  • 1. 266300 胶州市人民医院南院病房药房
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy and safety of Pevisone combined with tanshinone in the treatment of facial seborrheic dermatitis.Methods 120 cases of facial seborrheic dermatitis were randomly divided into two groups.Control group (n-60) was treated with Pevisone ointment,observation group (n=60) was treated with Pevisone and tanshinone,the course of treatment of two groups was 4 weeks.The degree of skin lesions before and after treatment,efficacy,and adverse reactions in two groups were observed.Results The total efficiency in observation group was 96.7%,and higher than 83.4% in control group,with statistically significant difference (P<0.05).There were no statistically significant differences in the scores of itching,scaling,erythema,the total score of skin lesions between two groups before treatment (P>0.05),the scores of itching,scaling,erythema,the total score of skin lesions in two groups significantly decreased after treatment,the extent of reduction in observation group was significantly greater,with statistically significant differences (P<0.05).The incidence of adverse reactions in observation group was significantly lower than that in control group (6.7% vs.16.7%),with statistically significant difference (P<0.05).Conclusion Pevisone ointment combined with tanshinone in the treatment of facial seborrheic dermatitis has remarkable curative effect,safe and reliable,which is worth promotion and application in clinical.

关键词

派瑞松软膏/丹参酮/脂溢性皮炎

Key words

Pevisone ointment/Tanshinone/Seborrheic dermatitis

引用本文复制引用

王晓丽,张美丽,栾照敏,王培圣..曲安奈德益康唑联合丹参酮治疗面部脂溢性皮炎的临床疗效研究[J].国际医药卫生导报,2017,23(4):557-559,3.

国际医药卫生导报

1007-1245

访问量0
|
下载量0
段落导航相关论文